| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Dennis D Kim last filed a Form 4 in January 2019, as Chief Medical Officer at LRMR. Dennis D Kim's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 21,443 shares of LRMR. The LRMR filings lean toward selling, a net 20,000 shares.
Dennis D Kim has 9 Form 4 filings on record from February 2015 to January 2019, all as Chief Medical Officer at Larimar Therapeutics (LRMR), 2015–2019.
The 15 reported transactions were 6 option or other derivative awards, 3 open-market purchases, 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to 2 purchases worth about $78K and 2 sales worth about $1.6M.
The largest open-market purchase was 10,000 shares of LRMR at an average $4.40 on May 11, 2017, about $44K.
The largest open-market sale was 39,407 shares of LRMR at an average $40.00 on September 17, 2015, about $1.6M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2017 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Buy | 10,000 | $3.39 | $33,900.00 | +87.4% | |
| May 11, 2017 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Buy | 10,000 | $4.40 | $44,000.00 | +693.0% | |
| Sep 17, 2015 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 39,407 | $40.00 | $1,576,280.00 | - | |
| Sep 14, 2015 | LRMR Larimar Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 593 | $40.00 | $23,720.00 | - |